BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/27/2026 6:07:05 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-11-13 04:48 |
|
Peer-Review Started |
|
2025-11-13 04:49 |
|
First Decision by Editorial Office Director |
|
2025-12-12 09:26 |
|
Return for Revision |
|
2025-12-12 09:26 |
|
Revised |
|
2025-12-18 21:00 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-19 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-19 07:28 |
|
Articles in Press |
|
2026-01-19 07:28 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-28 08:03 |
|
Publish the Manuscript Online |
|
2026-03-27 06:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Correspondence |
| Article Title |
AADN score predicts overall and progression-free survival in triple therapy for hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cristian Lindner |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Cristian Lindner, Department of Radiology, Faculty of Medicine, University of Concepción, San Martín 1436, Concepción 4030000, Chile. clindner146@gmail.com |
| Key Words |
Hepatocellular carcinoma; Oncology; Interventional radiology; Overall survival; Liver cancer |
| Core Tip |
The AADN score, derived from alpha-fetoprotein, alkaline phosphatase, direct bilirubin, and neutrophil-to-lymphocyte ratio, provides a simple yet powerful tool to predict overall and progression-free survival in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization, sintilimab, and lenvatinib. By integrating markers of tumor biology, hepatic function, and systemic inflammation, this model enables individualized risk stratification and supports precision-based decision-making in triple therapy for hepatocellular carcinoma. |
| Publish Date |
2026-03-27 06:07 |
| Citation |
Lindner C. AADN score predicts overall and progression-free survival in triple therapy for hepatocellular carcinoma. World J Gastroenterol 2026; 32(13): 116481 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i13/116481.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i13.116481 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
